BLAS
GIL EXTREMERA
Investigador en el periodo 2018-2019
Imperial College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Imperial College London (5)
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
2012
2010
-
The effect of treatment based on a diuretic (indapamide) ± ACE inhibitor (perindopril) on fractures in the hypertension in the very elderly trial (HYVET)
Age and Ageing, Vol. 39, Núm. 5, pp. 609-616
2003
-
Results of the pilot study for the Hypertension in the Very Elderly Trial
Journal of Hypertension, Vol. 21, Núm. 12, pp. 2409-2417